Valuation: ALTEOGEN Inc.

Market Cap 12,045B 9.02B 8.19B 7.57B 6.83B 12.89B 843B 13.38B 91.16B 36.06B 455B 33.85B 33.14B 1,437B P/E 2026 *
42.5x
P/E 2027 * 31.8x
Enterprise Value 11.57B 8.67M 7.87M 7.27M 6.56M 12.38M 810M 12.85M 87.59M 34.64M 437M 32.52M 31.84M 1.38B EV / Sales 2026 *
25.7x
EV / Sales 2027 * 17.5x
Free-Float
74.44%
Yield 2026 *
0.25%
Yield 2027 * 0.3%
1 day+0.76%
1 week-1.87%
Current month-18.20%
1 month-26.07%
3 months-44.90%
6 months-39.05%
Current year-49.97%
1 week 168,100
Extreme 168100.00000000
187,900
1 month 152,500
Extreme 152500
243,500
Current year 152,500
Extreme 152500
406,923.08
1 year 152,500
Extreme 152500
436,153.85
3 years 50,846.15
Extreme 50846.153846
437,692.31
5 years 21,442.31
Extreme 21442.307691
437,692.31
10 years 2,804.49
Extreme 2804.487177
437,692.31
Manager TitleAgeSince
Chief Executive Officer 61 26/12/2025
Director of Finance/CFO 61 28/03/2023
Corporate Officer/Principal - -
Director TitleAgeSince
Chairman 71 13/05/2008
Director/Board Member 70 29/03/2021
Director/Board Member 61 28/03/2023
Date Insider Type Main position Quantity % Market Cap. Importance
5/21/25 A Exercice

Chief Executive Officer

7,200 0.0135%
3/27/24 A Sell 1,600,000 3.0182%
1/5/24 A Sell 6,000 0.0115%
Change 5-day change 1-year change 3-year change Capi.($)
+0.76%-1.87%-58.96%+225.00% 9.02B
-1.13%-1.17%+38.55%+139.23% 1,261B
-1.36%-0.74%+39.64%+86.06% 671B
-0.59%-0.36%+25.14%+111.73% 518B
-0.06%+1.00%+32.34%+71.16% 387B
-0.75%-3.16%+54.39%+40.90% 353B
-0.49%-0.03%+30.10%+57.45% 300B
-0.74%-1.41%+0.99%+35.56% 283B
-0.95%-1.57%+34.01%+72.55% 248B
+1.60%-0.36%+37.21%+125.66% 211B
Average -0.20%-0.90%+23.34%+96.53% 424B
Weighted average by Cap. -0.35%-0.56%+34.20%+95.96%

Financials

2026 *2027 *
Net sales 451B 338M 307M 283M 255M 482M 31.55B 501M 3.41B 1.35B 17.03B 1.27B 1.24B 53.8B 647B 484M 440M 406M 367M 692M 45.27B 718M 4.9B 1.94B 24.43B 1.82B 1.78B 77.18B
Net income 268B 201M 182M 168M 152M 286M 18.74B 297M 2.03B 802M 10.11B 753M 737M 31.95B 372B 278M 253M 233M 211M 397M 26B 413M 2.81B 1.11B 14.03B 1.04B 1.02B 44.32B
Net Debt -472B -353M -321M -296M -267M -505M -33.03B -524M -3.57B -1.41B -17.82B -1.33B -1.3B -56.31B -703B -526M -478M -441M -398M -752M -49.19B -781M -5.32B -2.1B -26.54B -1.98B -1.93B -83.86B
Projected Income Statement - Annual - ALTEOGEN Inc.
Logo ALTEOGEN Inc.
Alteogen Inc is a Korea-based company primarily engaged in the research, development, and sales of biopharmaceuticals. The Company develops, produces, and sells biopharmaceuticals, including biobetters and novel biopharmaceuticals, based primarily on hyaluronidase protein engineering technology, sustained-release biopharmaceutical technology, and next-generation antibody-drug conjugate technology. In addition, the Company is engaged in research, development, and commercialization of biosimilars.
Employees
181
Date Price Change Volume
17/11/26 ₩173,000.00 +0.76% 263,651
16/11/26 ₩171,700.00 -2.55% 230,909
13/11/26 ₩176,200.00 -0.68% 452,343
12/11/26 ₩177,400.00 -3.32% 438,060
11/11/26 ₩183,500.00 +4.08% 530,657
Trader
Investor
Global
Quality
ESG MSCI
BB
MarketScreener Ratings - ALTEOGEN Inc.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
173,000.00KRW
Average target price
358,333.33KRW
Spread / Average Target
+107.13%
  1. Stock Market
  2. Stocks
  3. A196170 Stock